1Verma ⅠM,Weitzman MD.Gene therapy:twenty-first century medicine[J].Annu Bev Biochem,2005,74:711-738.
2Park TG,Jeong JH,Kim SW.Current status of polymeric gene delivery systems[J].Adv Drug Deliv Rev,2006,58:467-486.
3Haupt S,Hanpt Y.Ⅰmportance of p53 for cancer onset and therapy[J].Anticancer Drugs,2006,17:725-732.
4Eipel C,Schuett H,Glawe C,et al.Pifi-thrin-alpha induced p53 inhibition does not affect liver regeneration after partial hepatectomy in mice[J].J Hepatol,2005,43:829-835.
5Muller M,Meyer M,Schilling T,et al.Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers[J].Ⅰnt J Oncol,2006,29:973-980.
6Oliveira AM,Ross JS,Fletcher JA.Tumor suppresser genes in breast cancer,the gatekeepers and the care takers[J].Am J Clin Pathol,2005,124:16-28.
7Fujiwara T,Tanaka N,Kanazawa S,et al.Multi center phase Ⅰ study of repeated intratumeral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer[J].J Clin OncoⅠ,2006,24:1689-1699.
8Ateneio ⅠA,Grace M,Bordens R,et al.Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase Ⅰ colorectal cancer trial[J].Cancer Gene Ther,2006,13:169-181.
9Noireaux V,Libchaber A.A vesicle bioreactor as a step toward an artificial cell assembly[J].Proc Natl Acad Sci USA,2004,101:17669-17674.
10Barraud L,Merle Po Soma E,et al.Ⅰncrease of doxombicin seusitivity by doxoruhicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo[J].J Hepatol,2005,42:736-743.
4He J, Gu D, Wu X, et al. Major causes of death among men and women in China[J]. N EnglJ Med, 2005, 353(11): 1124-1134.
5Yang TS, Wang CH, Hsieh RK, et al. Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I--II trial[J]. Area Oncol, 2002, 13(11): 1771-1778.
6Chodon D, Ramamurty N, Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line[J]. Toxicol in Vitro, 2007, 21(5): 887-891.
7Gupta S, Knowlton AA. HSP60, Bax, apotosis and the heart[J]. J Cell Mol Med, 2005, 9(1): 51--58.
8Gustafsson AB, Gotflieb RA. Bcl-2 family members and apopto--sis, taken to heart[J]. AmJ Physiol Cell Physiol, 2007, 292(1): C45-C51.
9Brenes O, Arce F, Gatjens-Boniche O, et al. Characterization of cell death events induced by anti--neoplastic drugs cisplatin, paclitaxel and 5--fluorouracil on human hepatoma cell lines: possible mechanisms of cell resistance[J]. Biomed Pharmacother, 2007, 61 (6): 347--355.
10Seong J. Challenge and hope in radiotherapy of hepatocellular carci- noma. Yonsei Med J, 2009, 50: 601-612.
